Thymoma is a rare tumour affecting the thymus, an organ located in the chest near the heart. In dogs, the thymus plays a key role in the development of the immune system, particularly in the early stages of life. Thymomas in dogs are rare but important to understand, as they can have significant effects on health and can be associated with other immune-related conditions.
A thymoma is a tumour originating from the epithelial cells of the thymus gland. In dogs, thymomas can be classified as non-invasive (encapsulated) or invasive, depending on whether they are contained within the thymic capsule or have begun to infiltrate surrounding tissues. Most thymomas in dogs are benign or non-invasive, but invasive thymomas and thymic carcinomas (malignant thymic tumours) also occur.
Clinical signs vary depending on the size of the tumour and whether it is causing compression of nearby structures or associated conditions. Common presentations include:
Thymoma in dogs is associated with several paraneoplastic conditions — conditions that arise as a consequence of the tumour’s effects on the immune system rather than from direct tumour invasion. The most important of these is myasthenia gravis, an immune-mediated neuromuscular disease. Myasthenia gravis can cause generalised muscle weakness and a condition called megaoesophagus, in which the oesophagus is abnormally dilated and unable to move food into the stomach effectively. Megaoesophagus carries a significant risk of aspiration pneumonia, which is a serious complication.
Diagnosis typically involves imaging of the chest, usually computed tomography (CT) scan, which allows detailed assessment of the tumour’s size, location, and invasiveness. Additional tests may include blood tests, assessment for myasthenia gravis (acetylcholine receptor antibody titre), and evaluation for other paraneoplastic conditions.
Surgical removal (thymectomy) is the treatment of choice for non-invasive thymomas, and outcomes can be good in uncomplicated cases. Invasive thymomas are more challenging to treat surgically, and radiation therapy or chemotherapy may be considered. Management of associated conditions such as myasthenia gravis and megaoesophagus is also important and can significantly affect the prognosis.